SUBSIDIARY GUARANTEESubsidiary Guarantee • April 5th, 2012 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
SUBSIDIARY GUARANTEE, dated as of April 2, 2012 (this “Guarantee”), made by Adamis Corporation, a Delaware corporation, Adamis Laboratories, Inc., a Delaware corporation, and Adamis Viral Therapies, Inc., a Delaware corporation (collectively and together with any other entity that may become a party hereto as provided herein, the “Guarantor”, and together with the Company (as defined below), the “Debtors”), in favor of the purchaser (including such purchaser’s successors, transferees and assigns, the “Purchaser”) signatory to the Purchase Agreement (as defined below).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 5th, 2012 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations
This Securities Purchase Agreement (“Agreement”) is entered into as of April 2, 2012 by and between ADAMIS PHARMACEUTICALS CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and GEMINI MASTER FUND, LTD., a Cayman Islands corporation (“Purchaser”).
ADAMIS PHARMACEUTICALS CORPORATION 10% SENIOR CONVERTIBLE NOTEAdamis Pharmaceuticals Corp • April 5th, 2012 • Pharmaceutical preparations • New York
THIS NOTE is a duly authorized and validly issued 10% Senior Convertible Note of ADAMIS PHARMACEUTICALS CORPORATION, a Delaware corporation (the “Company”), having its principal place of business at 11455 El Camino Real, Suite 310, San Diego, CA 92130 (this “Note”).
